A carregar...

PARP Inhibitors Talazoparib and Niraparib Sensitize Melanoma Cells to Ionizing Radiation

(1) Background: Niraparib and Talazoparib are poly (ADP-ribose) polymerase (PARP) 1/2 inhibitors. It is assumed that combining PARP inhibitors with radiotherapy could be beneficial for cancer treatment. In this study, melanoma cells were treated with Niraparib and Talazoparib in combination with ion...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Genes (Basel)
Main Authors: Jonuscheit, Stephanie, Jost, Tina, Gajdošová, Fritzi, Wrobel, Maximilian, Hecht, Markus, Fietkau, Rainer, Distel, Luitpold
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8229922/
https://ncbi.nlm.nih.gov/pubmed/34073147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/genes12060849
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!